Search results

719 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Ramsden, Gupta awarded 5-year, $8.8 million grant to study enzyme with important implications for breast and ovarian cancers
The National Cancer Institute has awarded a team led by UNC Lineberger’s Dale Ramsden, PhD, professor in the UNC School of Medicine Department of Biochemistry and Biophysics, a five-year, $8.8 million program project grant to study an enzyme called DNA polymerase theta.
Located in News / 2020 / September
Tom Shea: Looking back at 27 years of cancer care at UNC
Thomas C. Shea, MD, who recently retired after nearly three decades of service to the North Carolina Cancer Hospital, has always been driven by the need to serve others.
Located in Vital Signs / 2020 / Aug. 20
CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA
Based on proof-of-concept results from clinical trials at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.
Located in News / 2020 / March
Researchers develop method to engineer immune cells so they grow even in hostile tumors
Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, report in the journal Nature Biotechnology they have created a method for providing a stimulatory signal to super-charge cancer-hunting immune cells, called chimeric antigen receptor T-cells, that have been genetically engineered to hunt and kill specific cancers.
Located in News / 2020 / February
Nyrop Receives Grant to Study Interventions for Racial Disparities in Breast Cancer Survival
Kirsten Nyrop, PhD, UNC Lineberger member and assistant professor of hematology/oncology, has received a $50,000 award from the Integrated Approach to Breast Health Equity Competitive Grant Program, a collaboration between the American Cancer Society and Pfizer.
Located in News / 2020 / February
UNC Hospitals' Pharmacy Department Wins 2019 ACCC Innovator Award
The Innovator Awards recognize Association of Community Cancer Center member programs for their ingenuity and pioneering achievements in oncology. Innovations advance the goals of improving access, quality, and value in cancer care delivery.
Located in Vital Signs / 2019 / November 7
Researchers identify possible approach to block medulloblastoma growth
UNC Lineberger’s Timothy Gershon, MD, PhD, and colleagues have identified a potential approach to stop the growth of the most common type of brain tumor in children. Their research was published in the journal Development.
Located in News / 2019 / October
2019 Oncology Excellence Awards celebrate compassionate nurses and staff
The awards honor oncology nurses, allied health professionals, and administrative staff for exceptional care of and devotion to individuals with cancer and their families and to the oncology profession.
Located in News / 2019 / October
NCI grant to help patients navigate costs of cancer care
UNC Lineberger’s Stephanie Wheeler, PhD, MPH, and Donald Rosenstein, MD, will use the grant to connect cancer patients with potential financial support resources in Carteret, Dare, Jackson, Lenoir, and Nash counties.
Located in News / 2019 / October
N.C. Cancer Hospital: A decade of hope and healing
This fall marks 10 years since the opening of the North Carolina Cancer Hospital, a state-of-the-art cancer center built by the people of North Carolina for the people.
Located in News / 2019 / October